Search research articles
Contact Us
Filters
Showing results (861-870 of 898) with videos related to
Page
of 90
Sort By:
Nature Cancer
|
March 25, 2022
Immune responses against SARS-CoV-2 variants after two and three doses of vaccine in B-cell malignancies: UK PROSECO study
Sean H Lim, Beth Stuart, Debora Joseph-Pietras, et al.
The Science of the Total Environment
|
January 26, 2019
Urban blue: A global analysis of the factors shaping people's perceptions of the marine environment and ecological engineering in harbours
E M A Strain, K A Alexander, S Kienker, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 28, 2023
Genomic characterisation of hormone receptor-positive breast cancer arising in very young women
S J Luen, G Viale, S Nik-Zainal, et al.
JCO Oncology Practice
|
September 8, 2023
Optimization of Advanced Molecular Genetic Testing Utilization in Hematopathology: A Goldilocks Approach to Bone Marrow Testing
Ali AlJabban, Henry Paik, Jon C Aster, et al.
Gynecologic Oncology
|
September 9, 2022
Unilateral inguinofemoral lymphadenectomy in patients with early-stage vulvar squamous cell carcinoma and a unilateral metastatic sentinel lymph node is safe
W L Van der Kolk, A G J Van der Zee, B M Slomovitz, et al.
Blood
|
February 19, 2025
Clinical-genomic profiling of MDS to inform allo-HCT: recommendations from an international panel on behalf of the EBMT
Carmelo Gurnari, Marie Robin, Lionel Adès, et al.
Nature Communications
|
February 27, 2021
Distinct genetic pathways define pre-malignant versus compensatory clonal hematopoiesis in Shwachman-Diamond syndrome
Alyssa L Kennedy, Kasiani C Myers, James Bowman, et al.
Physical Review Letters
|
October 13, 2007
Measurements of the decay KL-->e+ e- gamma
E Abouzaid, M Arenton, A R Barker, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 1, 2015
Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†
S Gourgou-Bourgade, D Cameron, P Poortmans, et al.
Science Translational Medicine
|
June 15, 2022
Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccine
Mathieu Gigoux, Morten O Holmström, Roberta Zappasodi, et al.
Page
of 90
Search research articles
Search
Showing results (861-870 of 898) with videos related to
Sort By:
Page
of 90
Nature Cancer
|
March 25, 2022
Immune responses against SARS-CoV-2 variants after two and three doses of vaccine in B-cell malignancies: UK PROSECO study
Sean H Lim, Beth Stuart, Debora Joseph-Pietras, et al.
The Science of the Total Environment
|
January 26, 2019
Urban blue: A global analysis of the factors shaping people's perceptions of the marine environment and ecological engineering in harbours
E M A Strain, K A Alexander, S Kienker, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 28, 2023
Genomic characterisation of hormone receptor-positive breast cancer arising in very young women
S J Luen, G Viale, S Nik-Zainal, et al.
JCO Oncology Practice
|
September 8, 2023
Optimization of Advanced Molecular Genetic Testing Utilization in Hematopathology: A Goldilocks Approach to Bone Marrow Testing
Ali AlJabban, Henry Paik, Jon C Aster, et al.
Gynecologic Oncology
|
September 9, 2022
Unilateral inguinofemoral lymphadenectomy in patients with early-stage vulvar squamous cell carcinoma and a unilateral metastatic sentinel lymph node is safe
W L Van der Kolk, A G J Van der Zee, B M Slomovitz, et al.
Blood
|
February 19, 2025
Clinical-genomic profiling of MDS to inform allo-HCT: recommendations from an international panel on behalf of the EBMT
Carmelo Gurnari, Marie Robin, Lionel Adès, et al.
Nature Communications
|
February 27, 2021
Distinct genetic pathways define pre-malignant versus compensatory clonal hematopoiesis in Shwachman-Diamond syndrome
Alyssa L Kennedy, Kasiani C Myers, James Bowman, et al.
Physical Review Letters
|
October 13, 2007
Measurements of the decay KL-->e+ e- gamma
E Abouzaid, M Arenton, A R Barker, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 1, 2015
Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†
S Gourgou-Bourgade, D Cameron, P Poortmans, et al.
Science Translational Medicine
|
June 15, 2022
Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccine
Mathieu Gigoux, Morten O Holmström, Roberta Zappasodi, et al.
Page
of 90